Pharmacokinetic analysis of cefozopran in neonatal infections: Population pharmacokinetics using nonmem

Japanese Journal of Antibiotics

Volumn 52, Issue 1, 1999, Pages 16-23

  Sakurai, Yuichi ^a   Hishikawa, Tamotsu ^a   Hiramatsu, Nobuyoshi ^a   Sagara, Yasuhito ^a   Kuwahara, Masaaki ^a   Nagasaki, Masaru ^a   Hujimaki, Tomoko ^a   Fuji, Ryochi ^b  

^a TAKEDA PHARMACEUTICAL COMPANY LIMITED   (Japan)

^b Res Inst Chemother Mother Child

Author keywords

[No Author keywords available]

Indexed keywords

CEFOZOPRAN;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG ELIMINATION; FEMALE; HUMAN; MALE; NEWBORN; NEWBORN INFECTION;

CEPHALOSPORINS; FEMALE; HUMANS; INFANT, NEWBORN; INFECTION; MALE; STATISTICS;

EID: 0033038977     PISSN: 03682781     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. MIYAKE, A.; Y. YOSHIMURA, M. YAMAOKA, T, NISHIMURA, N. HASHIMOTO & A. IMADA: Studies on condensed-heterocyclic azolium cephalosporins. IV. Synthesis and antibacterial activity of 7β-[2-(5-amino-1,2,4-thiadiazol-3-yl)-2(Z)-alkoxyiminoacetamido]-3- (condensed-heterocyclic azolium) methyl cephalosporins including SCE-2787. J. Antibiotics 45: 709-720, 1992
2. β-lactam 34: 2818-2825, 1981
3. IWAI, T.; K, OSCONOGI, T. YAMAZAKI, S. SHIKI, M. KONDO, A. MIYAKE & A. IMADA: In vitro and in vivo activities of SCE-2787, a new parenteral cephalosporin with a broad antibacterial spectrum. Antimicr. Agents & Chemoth. 36: 1358-1366, 1992
4. NAKAO, M.; Y. NOJI, T. IWAHI & T.YAMAZAKI: Antibacterial properties of SCE-2787, a new cephem antibiotic. J. Antimicr. Chemoth 29: 509-518, 1992
5. FUJII, R.; T. ABE, T TAJIMA, et al Pharmacokinetics and clinical effects of cefozopran in pediatric patients. Jpn. J. Antibiotics 49: 17-33, 1996
6. Cefozopran Jpn. J. Antibiotics 49: 678-702, 1996
7. Chemotherapy 41 (Suppl. 4): 135 -141, 1993